BD Acquires Tepha, Inc., to Drive New Innovations in Soft Tissue Repair and Regeneration
FRANKLIN LAKES, N.J., July 27, 2021 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Tepha, Inc., a leading developer and manufacturer... Devices, Regenerative Medicine, Mergers & Acquisitions BD , Tepha inc (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 27, 2021 Category: Pharmaceuticals Source Type: news

Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
SEATTLE, July 27, 2021 -- (Healthcare Sales & Marketing Network) -- Umoja Biopharma, an oncology company leveraging its proprietary integrated technologies to reprogram immune cells in vivo to create next-generation immunotherapies for the treatment of so... Biopharmaceuticals, Personnel Umoja Biopharma, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 27, 2021 Category: Pharmaceuticals Source Type: news

MicroPort(R) Cardiac Rhythm Management Business Announces US$150 Million Series C Investment
SHANGHAI, July 27, 2021 -- (Healthcare Sales & Marketing Network) -- MicroPort Scientific Corporation ("MicroPort®") announced that MicroPort Cardiac Rhythm Management Limited ("MicroPort® CRM"), which is MicroPort®'s subsi... Devices, Cardiology, Venture Capital MicroPort Scientific, MicroPort CRM, pacemaker, defibrillator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 27, 2021 Category: Pharmaceuticals Source Type: news

Court dismisses class action suit against Mylan regarding EpiPen
Viatris Inc. on Tuesday announced that a class action lawsuit filed almost four years ago against predecessor company Mylan NV regarding the pricing and marketing of emergency allergy medication EpiPen has been dismissed by a Kansas court. Viatris (NASDAQ: VTRS) said in a release that the U.S. District Court for the District of Kansas granted Mylan's motion to dismiss in a lawsuit brought against it and Pfizer Inc. by KPH Healthcare Services Inc. on behalf of an asserted class of direct purchasers… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 27, 2021 Category: Health Management Authors: Patty Tascarella Source Type: news

BlueRock Therapeutics Announces New Board Chair, New President and CEO
CAMBRIDGE, Mass., July 26, 2021 -- (Healthcare Sales & Marketing Network) -- BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, announced today that Emile Nuwaysir, Ph.D., current President and CEO, ... Biopharmaceuticals, Neurology, Personnel BlueRock Therapeutics, Bayer AG, Parkinson's disease, engineered cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 26, 2021 Category: Pharmaceuticals Source Type: news

Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Medtronic Prevail DCB™ Designed to Treat Complex Lesions with Superior Deliverability, Rapid Absorption of Paclitaxel DUBLIN, July 26, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE: MDT), the global leader in medical technology,... Devices, Interventional, Cardiology, Regulatory Medtronic, Prevail DCB, percutaneous coronary intervention (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 26, 2021 Category: Pharmaceuticals Source Type: news

Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors
HOUSTON and SINGAPORE, July 26, 2021 -- (Healthcare Sales & Marketing Network) -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that internation... Biopharmaceuticals, Oncology, Personnel Hummingbird Bioscience, Rational Antibody Discovery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 26, 2021 Category: Pharmaceuticals Source Type: news

This Vermont Utility Is Revolutionizing Its Power Grid to Fight Climate Change. Will the Rest of the Country Follow Suit?
Visitors entering a code-locked central control room at Green Mountain Power (GMP)’s Colchester, Vt., headquarters instinctively lower their voices, whispering in deference to operators relaying orders from behind semicircular clusters of screens. It’s an intimidating space; one side of the black-walled room is taken up by a display showing a sprawling, yellow-lit maze of connections and symbols: a map of electricity flowing across the local grid. Technicians here have the daunting job of managing that vast, interconnected network; controlling hundreds of breaker switches; monitoring solar and hydroelectric ele...
Source: TIME: Science - July 26, 2021 Category: Science Authors: Alejandro de la Garza/Panton, Vt. Tags: Uncategorized Source Type: news

Evaluation of the Lifejackets for Lobstermen program: a social marketing initiative to increase lifejacket use in the Northeast lobster fishing industry - Sorensen JA, Weil R, Echard J, Tinc P, Hirabayashi L, Roome A, Lally E, Jenkins P.
Background Fatality data from the U.S. commercial fishing industry indicates workers in this industry suffer from comparatively high rates of work-related death, in relation to other U.S. industries. Falls overboard are the most frequent cause of death am... (Source: SafetyLit)
Source: SafetyLit - July 25, 2021 Category: International Medicine & Public Health Tags: Drowning, Suffocation Source Type: news

Tennessee resumes vaccination outreach but with marketing emphasis on parents, not children
(Source: Reuters: Health)
Source: Reuters: Health - July 24, 2021 Category: Consumer Health News Source Type: news

Biogen accused of over-marketing controversial new Alzheimer's drug Aduhelm
Biogen is under fire once again because of their controversial Alzheimer's drug, Aduhelm. An online survey published by the company recommends people for a cognitive screening no matter what. (Source: the Mail online | Health)
Source: the Mail online | Health - July 23, 2021 Category: Consumer Health News Source Type: news

Johnson and Johnson Vision Introduces VERITAS Vision System With Features To Address Key Unmet Needs In Cataract Surgery
High-performance, next-generation cataract surgery system is now globally available and offers surgeons enhanced safety and exceptional efficiency SANTA ANA, Calif., July 23, 2021 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Vision,* ... Devices, Ophthalmology, Product Launch Johnson & Johnson Vision, VERITAS Vision System, phacoemulsification, cataract (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 23, 2021 Category: Pharmaceuticals Source Type: news

ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim
New license and supply agreement will see ImaginAb supply Boehringer Ingelheim with its market leading CD8 ImmunoPET technology LOS ANGELES, July 23, 2021 -- (Healthcare Sales & Marketing Network) -- ImaginAb Inc, a market leading global biotechnology ... Biopharmaceuticals, Radiology, Licensing ImaginAb, Boehringer Ingelheim, radiopharmaceuticals, ImmunoPET (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 23, 2021 Category: Pharmaceuticals Source Type: news

Shedding light on the dark side of firm lobbying
(American Marketing Association) A firm's focus on customers may be diminished when it lobbies. Firm focus can be reoriented to customers, but doing so requires intentional, marketing-focused efforts. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 23, 2021 Category: International Medicine & Public Health Source Type: news

Anywhere pharma advertises, expect to be LIED TO about health and safety
(Natural News) America was built on advertising. Nearly every popular product today is promoted on television, in magazines, on billboards or on the internet by companies and corporations that pay millions of dollars for marketing ads. The people who own and run those lavishly rich companies and corporations make a fortune off customers in two... (Source: NaturalNews.com)
Source: NaturalNews.com - July 22, 2021 Category: Consumer Health News Source Type: news

Aducanumab for Alzheimer's disease: expediting approval and delaying science
At the beginning of this month of June, the Food and Drug Administration (FDA) announced its decision to grant marketing authorisation to the monoclonal antibody aducanumab, the first treatment option targeting and affecting the underlying disease process of Alzheimer's disease, according to the press release of the medicines regulatory agency of the USA. What should have been a source of joy and recognition of the success of basic and clinical sciences, however, resulted in a bitter dispute in the scientific community, that ended up in the resignation of three of the experts who had participated in the committee that advi...
Source: Current Awareness Service for Health (CASH) - July 22, 2021 Category: Consumer Health News Source Type: news

Hong Kong Sanatorium and Hospital Transforms Cancer Care in Asia with Treatment of First Patient Using the Accuray Radixact(R) System and ClearRT(TM) Helical Fan-Beam kVCT Imaging
ClearRT Significantly Improves Image Quality, Facilitating the Delivery of More Precise and Accurate Treatments to Patients SUNNYVALE, Calif., July 22, 2021 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced toda... Devices, Oncology Accuray, Radixact System, ClearRT, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 22, 2021 Category: Pharmaceuticals Source Type: news

NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery
SAN DIEGO, July 22, 2021 -- (Healthcare Sales & Marketing Network) -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced t... Devices, Neurosurgery, Orthopaedic, Product Launch NuVasive, Modulus ALIF, anterior lumbar interbody fusion, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 22, 2021 Category: Pharmaceuticals Source Type: news

Johnson & Johnson Statement on Nationwide Opioid Settlement Agreement
NEW BRUNSWICK, N.J., July 21, 2021 - Johnson & Johnson and its U.S.-based Janssen Pharmaceutical Companies today announced the finalization of a nationwide settlement agreement to resolve opioid-related claims and litigation by states, cities, counties, and other subdivisions in the United States. As previously announced, the Company will contribute up to $5 billion to the settlement, depending on the number of state and local governments that elect to opt into the agreement over the next several months. "We recognize the opioid crisis is a tremendously complex public health issue, and we have deep sympathy for ev...
Source: Johnson and Johnson - July 21, 2021 Category: Pharmaceuticals Source Type: news

FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System
OBERLIN, Ohio, July 21, 2021 -- (Healthcare Sales & Marketing Network) -- Synapse Biomedical, Inc®. (www.synapsebiomedical.com) announced today that the FDA has granted Breakthrough Therapy Device designation to TransAeris®, a temporary percutaneo... Devices, FDA Synapse Biomedical, TransAeris, diaphragm stimulator, mechanical ventilator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 21, 2021 Category: Pharmaceuticals Source Type: news

Balancing community input and established research: findings from the development of a sexual violence prevention campaign - Graham K, Potterton H, Mihaere T, Carrington B, Treharne GJ, Beres MA.
This article describes a focus group study exploring university students' perspectives of sexual violence prevention campaigns with the goal of developing a social marketing campaign that would resonate with university students. Seventy-one students at one... (Source: SafetyLit)
Source: SafetyLit - July 21, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Corium Launches Innovative ADHD Treatment AZSTARYS(TM) (serdexmethylphenidate and dexmethylphenidate) in the U.S. for Patients Age 6 Years and Older
AZSTARYS is the First and Only Product Containing Prodrug of Dexmethylphenidate Unique formulation provides rapid and extended duration symptom control BOSTON, July 21, 2021 -- (Healthcare Sales & Marketing Network) -- Corium, Inc., a commercial-sta... Biopharmaceutical, Neurology, Product Launch Corium Inc, AZSTARYS, ADHD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 21, 2021 Category: Pharmaceuticals Source Type: news

Study shows Smith and Nephew's REGENETEN(TM) Bioinductive Implant sets new standard of recovery for partial-thickness rotator cuff tears
LONDON, July 21, 2021 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announces study results showing patients treated with just its REGENETEN Bioinductive Implant for partial-th... Devices, Orthopaedic Smith & Nephew, REGENETEN Bioinductive Implant, rotator cuff tear (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 21, 2021 Category: Pharmaceuticals Source Type: news

PathogenDx Receives CE-IVD Mark for Its Microarray-Based DetectX-Rv Test for COVID-19
The low-cost, high-throughput test will now be available for qualified laboratories across the European Union SCOTTSDALE, Ariz., July 21, 2021 -- (Healthcare Sales & Marketing Network) -- PathogenDx, Inc., an Arizona based biotechnology company which h... Diagnostics, Regulatory PathogenDx, COVID-19 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 21, 2021 Category: Pharmaceuticals Source Type: news

Baltimore's b.well raises $32M to boost new sales, marketing push
The health tech company, which allows consumers to store their health data, says it doubled its business in 2020 amid the Covid-19 pandemic. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 21, 2021 Category: Pharmaceuticals Authors: Morgan Eichensehr Source Type: news

Johnson & Johnson Reports Q2 2021 Results
New Brunswick, N.J. (July 21, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter. “Our second-quarter results showcase Johnson & Johnson’s diversified portfolio, driven by strong sales and earnings growth across our Medical Device, Consumer Health and Pharmaceutical businesses,” said Alex Gorsky, Chairman and Chief Executive Officer. “I’m so proud of our 136,000 colleagues who remain focused on delivering our medicines and products to patients and consumers around the world, in addition to advancing our pipeline with new product launches and regulato...
Source: Johnson and Johnson - July 21, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Cellerant Best of Class Hygiene Award Program Launches for 2021
 Cellerant Best of Class Hygiene Award Program Launches for 2021Washington, DC; July 21, 2021 – Cellerant Consulting Group is excited to announce the launch of the inaugural Cellerant Best of Class Hygiene Award Program. “Since 2009, the Cellerant Best of Class Technology Awards have identified and acknowledged the top technologies in dentistry,” said Melissa Turner, Chief Hygiene Officer at Cellerant. “We will now expand the program to focus on the dental hygiene community as well. ”“We recognize the im...
Source: Dental Technology Blog - July 21, 2021 Category: Dentistry Source Type: news

First Light Diagnostics Receives FDA Clearance for its Rapid Clostridiodes difficile Test on the MultiPath(R) Analyzer
First FDA cleared product based on the Company's proprietary MultiPath technology CHELMSFORD, Mass., July 20, 2021 -- (Healthcare Sales & Marketing Network) -- First Light Diagnostics is developing and commercializing breakthrough automated diagnostic ... Diagnostics, FDA First Light Diagnostics, SensiTox, C. difficile test, Clostridium difficile (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 20, 2021 Category: Pharmaceuticals Source Type: news

Jeff Bezos Blasts Himself Off-Planet, Helping to Usher In a New Era of Space Tourism
Give Jeff Bezos this: When he builds a rocket, he rides the rocket, strapping his own mortal hide into a seat and test-flying what he’s developed before inviting paying passengers aboard to make the same journey. “If it’s not safe for me, it’s not safe for anyone,” Bezos said in a video segment released by Blue Origin, his private rocket company, before Tuesday morning’s first crewed launch of its New Shepard rocket on a suborbital lob shot that soared to an altitude of 106 km (66 mi.). Today, the rocket—which had previously flown 15 uncrewed missions to suborbital space—inde...
Source: TIME: Science - July 20, 2021 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized Source Type: news

Alma, a Sisram Medical Company, Announces FDA Clearance and the U.S. Launch of Alma Hybrid(TM)
BUFFALO GROVE, Ill., July 20, 2021 -- (Healthcare Sales & Marketing Network) -- Alma, a global leader in the energy-based medical and aesthetic solutions industry announced the U.S. Food and Drug Administration 510(k) clearance of Alma Hybrid™, the first ... Devices, Dermatology, FDA, Product Launch Alma Lasers, Alma Hybrid, laser, skin resurfacing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 20, 2021 Category: Pharmaceuticals Source Type: news

Pharming signs agreement with NewBridge Pharmaceuticals for the commercialization of RUCONEST(R) in the Middle East and North Africa
LEIDEN, Netherlands, July 20, 2021 -- (Healthcare Sales & Marketing Network) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces it has entered into an exclusive licence agreement w... Biopharmaceuticals, Licensing, Distribution Pharming Group, NewBridge Pharmaceuticals, RUCONEST, hereditary angioedema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 20, 2021 Category: Pharmaceuticals Source Type: news

Regulatory approval of Vaxzevria (previously COVID-19 Vaccine AstraZeneca) , MHRA (updated 19th July 2021)
Information for healthcare professionals and the public about Vaxzevria (previously COVID-19 Vaccine AstraZeneca). 19 July 2021 Added Lay summary, Vaxzevria (previously COVID‑19 Vaccine AstraZeneca, suspension for injection) COVID-19 Vaccine (ChAdOx1‑S [recombinant]) 16 July 2021 Updated to reflect the addition of capillary leak syndrome a s a contraindication. Also changed the name of the COVID-19 Vaccine AstraZeneca in the Conditional Marketing Authorisation product information to the brand name - Vaxzevria. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 20, 2021 Category: Consumer Health News Source Type: news

Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
SAN FRANCISCO, July 19, 2021 -- (Healthcare Sales & Marketing Network) -- Nektar Therapeutics (Nasdaq: NKTR) announced today that it has appointed Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer (CMO). In his role as C... Biopharmaceuticals, Personnel Nektar Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 19, 2021 Category: Pharmaceuticals Source Type: news

BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease
CAMBRIDGE, Mass., July 19, 2021 -- (Healthcare Sales & Marketing Network) -- BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced that the U.S. Food and Drug Administration (FDA) has grant... Regenerative Medicine, Neurology, FDA BlueRock Therapeutics, Bayer, Parkinson's disease, engineered cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 19, 2021 Category: Pharmaceuticals Source Type: news

A content analysis of YouTube depression personal account videos and their comments - Gaus Q, Jolliff A, Moreno MA.
Around 20% of teens seeking health information about depression online watch YouTube videos to find the information. However, the content of depression-related YouTube videos remains understudied. Thus, the purpose of this study is to identify if DPAVs ref... (Source: SafetyLit)
Source: SafetyLit - July 18, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Development and validation of the TAR Scale: a measure of technology-facilitated abuse in relationships - Brown C, Hegarty K.
Technology-facilitated abuse in relationships (TAR) occurs frequently in young people's dating relationships, however the development of TAR measurement is limited. Existing instruments examining youth TAR confine measurement to specific digital devices an... (Source: SafetyLit)
Source: SafetyLit - July 18, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

The portrayal of online shaming in contemporary online news media: a media framing analysis - Muir SR, Roberts LD, Sheridan LP.
Online shaming, where individuals participate in social policing by shaming supposed wrongdoings on the internet, is a rapidly increasing and global phenomenon. The potential impacts of online shaming are said to be extensive and wide-reaching, however min... (Source: SafetyLit)
Source: SafetyLit - July 18, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Tweet valence, volume of abuse, and observers' dark tetrad personality factors influence victim-blaming and the perceived severity of twitter cyberabuse - Hand CJ, Scott GG, Brodie ZP, Ye X, Sereno SC.
Previous research into Twitter cyberabuse has yielded several findings: victim-blaming (VB) was influenced by victims' initial tweet-valence; perceived severity (PS) was influenced independently by tweet valence and abuse volume; VB and PS were predicted b... (Source: SafetyLit)
Source: SafetyLit - July 18, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Examining ideologically motivated cyberattacks performed by far-left groups - Holt TJ, Stonhouse M, Freilich J, Chermak SM.
Over the last two decades, there has been a massive increase in research examining terror and extremist-related violence. Few have considered the extent to which these same groups may engage in attacks against digital infrastructure and the Internet, wheth... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Jealousy and electronic intrusion mediated by relationship uncertainty in married and cohabiting couples during COVID-19 - Ligman K, Rodriguez LM, Rocek G.
The COVID-19 pandemic poses unique threats to romantic relationships as couples were issued to stay at home by a mandatory order, limiting social interactions with others. Although technology allows for social interactions, the privacy of interactions thro... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Multifeature fusion attention network for suicide risk assessment based on social media: algorithm development and validation - Li J, Zhang S, Zhang Y, Lin H, Wang J.
BACKGROUND: Suicide has become the fifth leading cause of death worldwide. With development of the internet, social media has become an imperative source for studying psychological illnesses such as depression and suicide. Many methods have been proposed f... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Social media mechanisms for right-wing political violence in the 21st century: discursive opportunities, group dynamics, and co-ordination - Wahlstr öm M, Törnberg A.
This article maps mechanisms by which online social media activities may contribute to right-wing political violence. High-impact studies on the wave of right-wing and racist violence in the 1990s and early 2000s established that mass media discourse on im... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

The terrorism information environment: analysing terrorists' selection of ideological and facilitative media - Holbrook D.
This article studies media material which individuals who planned or carried out acts of terrorism in the United Kingdom between 2004 and 2017 collected before their involvement in these activities concluded. It explores the nature and type of content foun... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

User engagement and usability of suicide prevention apps: systematic search in app stores and content analysis - Wilks CR, Chu C, Sim DG, Lovell J, Gutierrez P, Joiner T, Kessler RC, Nock MK.
BACKGROUND: People with suicidal thoughts are more inclined to seek technology-delivered interventions than in-person forms of treatment, making mobile apps for suicide prevention an ideal platform for treatment delivery. This review examines apps designed... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Using migration data to fine-tune marketing strategies to rural Indian communities
(American Marketing Association) Migration is a major phenomenon across developing economies. Marketers and policymakers should harness the power of migrants' remittances--both economic and social--to allocate marketing resources. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 16, 2021 Category: International Medicine & Public Health Source Type: news

Netflix Fires Marketing Execs for Criticizing Bosses Over Slack
Netflix has dismissed three senior film marketing executives — about half its staff at that level — after they were discovered grousing... (Source: Reuters: Health)
Source: Reuters: Health - July 15, 2021 Category: Consumer Health News Source Type: news

Aeglea BioTherapeutics Appoints Jim Kastenmayer as General Counsel
AUSTIN, Texas, July 15, 2021 -- (Healthcare Sales & Marketing Network) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metaboli... Biopharmaceuticals, Personnel Aeglea BioTherapeutics, pegzilarginase, Arginase 1 Deficiency (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 15, 2021 Category: Pharmaceuticals Source Type: news

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients
World-leading surgeons to join iSTAR Medical's STAR-V study WAVRE, Belgium, July 15, 2021 -- (Healthcare Sales & Marketing Network) -- iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today... Devices, Ophthalmology, FDA iSTAR Medical, micro-invasive glaucoma surgery, MINIject , glaucoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 15, 2021 Category: Pharmaceuticals Source Type: news

Leading quantum computing experts explore tech's sustainability role in new documentary
(HKA Marketing Communications) The trailer for a new documentary short titled " Quantum Technology | Our Sustainable Future " was released today. Scheduled for a world premiere July 29, the documentary features insights by scientists from tech giants such as Google, IBM and Intel as well as start-ups and government agencies on the potential of applying quantum technology to solve key sustainability issues. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 15, 2021 Category: Biology Source Type: news

RxS, LLC Expands U.S. Footprint in Fort Lauderdale, FL
Leader in Multi-Channel Sample Management and Marketing Provider Opens a New Location in Florida.(PRWeb July 15, 2021)Read the full story at https://www.prweb.com/releases/rxs_llc_expands_u_s_footprint_in_fort_lauderdale_fl/prweb18072837.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 15, 2021 Category: Pharmaceuticals Source Type: news